238 related articles for article (PubMed ID: 24062393)
1. Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia.
Bochtler T; Stölzel F; Heilig CE; Kunz C; Mohr B; Jauch A; Janssen JW; Kramer M; Benner A; Bornhäuser M; Ho AD; Ehninger G; Schaich M; Krämer A
J Clin Oncol; 2013 Nov; 31(31):3898-905. PubMed ID: 24062393
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
Baron F; Stevens-Kroef M; Kicinski M; Meloni G; Muus P; Marie JP; Halkes CJM; Thomas X; Vrhovac R; Specchia G; Lefrere F; Sica S; Mancini M; Venditti A; Hagemeijer A; Becker H; Jansen JH; Amadori S; de Witte T; Willemze R; Suciu S
Ann Hematol; 2018 Oct; 97(10):1785-1795. PubMed ID: 29926156
[TBL] [Abstract][Full Text] [Related]
3. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
[TBL] [Abstract][Full Text] [Related]
5. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.
Breems DA; Van Putten WL; De Greef GE; Van Zelderen-Bhola SL; Gerssen-Schoorl KB; Mellink CH; Nieuwint A; Jotterand M; Hagemeijer A; Beverloo HB; Löwenberg B
J Clin Oncol; 2008 Oct; 26(29):4791-7. PubMed ID: 18695255
[TBL] [Abstract][Full Text] [Related]
6. Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia.
Bochtler T; Granzow M; Stölzel F; Kunz C; Mohr B; Kartal-Kaess M; Hinderhofer K; Heilig CE; Kramer M; Thiede C; Endris V; Kirchner M; Stenzinger A; Benner A; Bornhäuser M; Ehninger G; Ho AD; Jauch A; Krämer A;
Blood; 2017 Mar; 129(10):1333-1342. PubMed ID: 28119329
[TBL] [Abstract][Full Text] [Related]
7. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
8. CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavorable acute myeloid leukemia.
Chen MH; Atenafu E; Craddock KJ; Brandwein J; Chang H
Leuk Res; 2013 Feb; 37(2):122-8. PubMed ID: 23092917
[TBL] [Abstract][Full Text] [Related]
9. Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).
Niederwieser C; Nicolet D; Carroll AJ; Kolitz JE; Powell BL; Kohlschmidt J; Stone RM; Byrd JC; Mrózek K; Bloomfield CD
Haematologica; 2016 Dec; 101(12):1516-1523. PubMed ID: 27470602
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
12. Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia.
Oran B; Dolan M; Cao Q; Brunstein C; Warlick E; Weisdorf D
Biol Blood Marrow Transplant; 2011 Mar; 17(3):356-64. PubMed ID: 20553926
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression.
Junghanss C; Waak M; Knopp A; Kleine HD; Kundt G; Leithäuser M; Hilgendorf I; Wolff D; Casper J; Freund M
Neoplasma; 2005; 52(5):402-10. PubMed ID: 16151585
[TBL] [Abstract][Full Text] [Related]
14. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia.
Fröhling S; Kayser S; Mayer C; Miller S; Wieland C; Skelin S; Schlenk RF; Döhner H; Döhner K;
Haematologica; 2005 Feb; 90(2):194-9. PubMed ID: 15710571
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia.
Medeiros BC; Othus M; Fang M; Appelbaum FR; Erba HP
Haematologica; 2015 Mar; 100(3):331-5. PubMed ID: 25527568
[TBL] [Abstract][Full Text] [Related]
17. Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype.
Yi JH; Huh J; Kim HJ; Kim SH; Kim HJ; Kim YK; Sohn SK; Moon JH; Kim SH; Kim KH; Won JH; Mun YC; Kim H; Park J; Jung CW; Kim DH
J Clin Oncol; 2011 Dec; 29(35):4702-8. PubMed ID: 22084373
[TBL] [Abstract][Full Text] [Related]
18. Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.
Middeke JM; Beelen D; Stadler M; Göhring G; Schlegelberger B; Baurmann H; Bug G; Bellos F; Mohr B; Buchholz S; Schwerdtfeger R; Martin H; Hegenbart U; Ehninger G; Bornhäuser M; Schetelig J;
Blood; 2012 Sep; 120(12):2521-8. PubMed ID: 22855604
[TBL] [Abstract][Full Text] [Related]
19. Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.
Mohr B; Schetelig J; Schäfer-Eckart K; Schmitz N; Hänel M; Rösler W; Frickhofen N; Link H; Neubauer A; Schuler U; Platzbecker U; Middeke JM; Ehninger G; Bornhäuser M; Schaich M; Stölzel F;
Br J Haematol; 2013 Apr; 161(2):237-44. PubMed ID: 23432431
[TBL] [Abstract][Full Text] [Related]
20. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
